| Bret E Heskett, MD | |
|
1000 Hospital Dr, Mcpherson, KS 67460-2326 | |
| (620) 241-7400 | |
| (620) 798-2613 |
| Full Name | Bret E Heskett |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 17 Years |
| Location | 1000 Hospital Dr, Mcpherson, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306054952 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 04-34977 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Kansas Health System - St Francis Campus | Topeka, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Topeka Physician Group Llc | 6406112473 | 141 |
News Archive
A crucial reorganization process that occurs in the adolescent brain may be disturbed in those who go on to develop schizophrenia, a study suggests.
By developing a novel decoding technology, a team of engineers and physicians at the University of Southern California and UC San Francisco have discovered how mood variations can be decoded from neural signals in the human brain-a process that has not been demonstrated to date.
Patients are more likely to have better health outcomes if they are treated at hospitals using information technology (IT) systems, according to a comprehensive new Florida State University study.
Boehringer Ingelheim Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration has approved once-daily Mirapex ER® (pramipexole dihydrochloride) extended-release tablets for the signs and symptoms of idiopathic Parkinson's disease, which includes early and advanced PD. PD is the second most common chronic neurological disorder in older adults after Alzheimer's. Parkinson's disease has no cure.
› Verified 8 days ago
| Entity Name | Hutchinson Clinic P A Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043298474 PECOS PAC ID: 5597658492 Enrollment ID: O20040204000969 |
News Archive
A crucial reorganization process that occurs in the adolescent brain may be disturbed in those who go on to develop schizophrenia, a study suggests.
By developing a novel decoding technology, a team of engineers and physicians at the University of Southern California and UC San Francisco have discovered how mood variations can be decoded from neural signals in the human brain-a process that has not been demonstrated to date.
Patients are more likely to have better health outcomes if they are treated at hospitals using information technology (IT) systems, according to a comprehensive new Florida State University study.
Boehringer Ingelheim Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration has approved once-daily Mirapex ER® (pramipexole dihydrochloride) extended-release tablets for the signs and symptoms of idiopathic Parkinson's disease, which includes early and advanced PD. PD is the second most common chronic neurological disorder in older adults after Alzheimer's. Parkinson's disease has no cure.
› Verified 8 days ago
| Entity Name | Topeka Physician Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770008849 PECOS PAC ID: 6406112473 Enrollment ID: O20171107002163 |
News Archive
A crucial reorganization process that occurs in the adolescent brain may be disturbed in those who go on to develop schizophrenia, a study suggests.
By developing a novel decoding technology, a team of engineers and physicians at the University of Southern California and UC San Francisco have discovered how mood variations can be decoded from neural signals in the human brain-a process that has not been demonstrated to date.
Patients are more likely to have better health outcomes if they are treated at hospitals using information technology (IT) systems, according to a comprehensive new Florida State University study.
Boehringer Ingelheim Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration has approved once-daily Mirapex ER® (pramipexole dihydrochloride) extended-release tablets for the signs and symptoms of idiopathic Parkinson's disease, which includes early and advanced PD. PD is the second most common chronic neurological disorder in older adults after Alzheimer's. Parkinson's disease has no cure.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bret E Heskett, MD 1000 Hospital Dr, Mcpherson, KS 67460-2326 Ph: (620) 241-7400 | Bret E Heskett, MD 1000 Hospital Dr, Mcpherson, KS 67460-2326 Ph: (620) 241-7400 |
News Archive
A crucial reorganization process that occurs in the adolescent brain may be disturbed in those who go on to develop schizophrenia, a study suggests.
By developing a novel decoding technology, a team of engineers and physicians at the University of Southern California and UC San Francisco have discovered how mood variations can be decoded from neural signals in the human brain-a process that has not been demonstrated to date.
Patients are more likely to have better health outcomes if they are treated at hospitals using information technology (IT) systems, according to a comprehensive new Florida State University study.
Boehringer Ingelheim Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration has approved once-daily Mirapex ER® (pramipexole dihydrochloride) extended-release tablets for the signs and symptoms of idiopathic Parkinson's disease, which includes early and advanced PD. PD is the second most common chronic neurological disorder in older adults after Alzheimer's. Parkinson's disease has no cure.
› Verified 8 days ago
Ruth M Lehman Wiens, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1000 Hospital Dr, Mcpherson, KS 67460 Phone: 316-741-7400 Fax: 620-798-2613 |